Welcome to the Emery Pharma Speaker Series. Today, we are pleased to introduce our speaker: Neda Razavi.
Neda Razavi serves as the CEO of iSono Health. With a background as a healthcare marketing executive encompassing biotech, medical devices, and biopharma, Neda brings a wealth of experience to her role.
Neda Razavi's academic journey includes earning a Bachelor of Science in microbiology with molecular and cellular biology from Tehran, followed by an MBA in finance from the Graziadio Business School of Management. Throughout her career, Neda has demonstrated a steadfast commitment to personalized medicine and enhancing patients' quality of life.
About iSono Health:
iSono Health is a company that provides an artificial intelligence (AI) platform for breast cancer screening. They have developed the ATUSA system, which is an AI-driven ultrasound scanner designed for 3D breast imaging. This system aims to offer accessible and personalized whole breast imaging at the point of care, enabling cost-effective and personalized monitoring of breast health. The ATUSA system has received FDA approval for breast imaging and is the world's first automated and portable 3D breast ultrasound scanner. It is designed to assist in early detection of abnormalities, track changes in breast health, and provide insightful data to physicians for better diagnosis and patient management.
About Emery Pharma:
Emery Pharma is deeply committed to advancing public health and exclusively focuses on projects that enhance the well-being of both individuals and the environment. As a comprehensive contract research laboratory, Emery Pharma provides extensive support across the entire spectrum of pharmaceutical development, covering small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.
Emery Pharma's array of premium services includes analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and comprehensive R&D with cGMP/GLP support. The Emery Pharma team excels in customizing innovative solutions tailored to the unique requirements of each client. They seamlessly oversee the entire process, from initial drug discovery to thorough data analysis and insights generation. Their expertise allows them to tackle scientific challenges proactively, ensuring clients avoid unnecessary setbacks.
Emery Pharma's accomplished chemists and biologists harness state-of-the-art technology, encompassing cutting-edge tools such as high-resolution mass spectrometry (Orbitrap), triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR.
For further details, please don't hesitate to reach out to Emery Pharma at info@emerypharma.com or explore their website at:
emerypharma.com/
30 сен 2024
